ReviewJournal of inherited metabolic disease2003

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.

T M Cox et al.PubMed ↗Publisher ↗

No numbers read from the abstract.